A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Lethal in combination with Df(2R)BSC594.
The presence of P+PBac{XP5.WH5}BSC883 was verified using the PCR methods and primers described in FBrf0175003.
The breakpoints of Df(2R)BSC883 predicted from the Release 5 genomic coordinates of the progenitor P{XP}d02243 and PBac{WH}CG11048f00140 transposable element insertion sites are 2R:15519525 ;16130288 and the cytological breakpoints predicted from these coordinates are 56E1;56F11.